Australia markets closed

Lysogene S.A. (LYSGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.50000.0000 (0.00%)
At close: 10:57AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
3,731
3,731
13,369
13,373
3,590
Cost of revenue
1,889
1,889
2,620
2,484
-
Gross profit
1,842
1,842
10,749
10,889
-
Operating expenses
Research development
15,661
15,661
16,307
17,624
10,705
Selling general and administrative
449
449
497
620
6,194
Total operating expenses
15,133
15,133
15,826
15,972
14,575
Operating income or loss
-13,291
-13,291
-5,077
-5,083
-10,985
Interest expense
62
62
-
-
83
Income before tax
-13,609
-13,609
-5,091
-4,282
-10,913
Income tax expense
0
0
0
0
43
Income from continuing operations
-13,609
-13,609
-5,091
-4,282
-10,956
Net income
-13,609
-13,609
-5,091
-4,282
-10,925
Net income available to common shareholders
-13,609
-13,609
-5,091
-4,282
-10,925
Basic EPS
-
-
-0.32
-0.31
-0.87
Diluted EPS
-
-
-0.32
-0.31
-0.87
Basic average shares
-
-
15,799
13,594
12,579
Diluted average shares
-
-
15,799
13,594
12,579
EBITDA
-
-13,183
-4,713
-4,842
-10,798